Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Study of Coagulation Factor VIIa Marzeptacog Alfa (Activated) in Subjects With Inherited Bleeding Disorders

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04548791
Recruitment Status : Terminated (Company decision (not a safety issue))
First Posted : September 16, 2020
Last Update Posted : December 21, 2021
Information provided by (Responsible Party):
Catalyst Biosciences

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : November 15, 2021
Actual Study Completion Date : December 3, 2021